Cargando...

Role of STAT3 in Transformation and Drug Resistance in CML

Chronic myeloid leukemia (CML) is initially driven by the bcr–abl fusion oncoprotein. The identification of bcr–abl led to the discovery and rapid translation into the clinic of bcr–abl kinase inhibitors. Although, bcr–abl inhibitors are efficacious, experimental evidence indicates that targeting bc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Nair, Rajesh R., Tolentino, Joel H., Hazlehurst, Lori A.
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Research Foundation 2012
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3355894/
https://ncbi.nlm.nih.gov/pubmed/22649784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2012.00030
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!